Immunic, Inc. short interest in 2023
In 2023, Immunic, Inc.'s disclosed short interest ran from 17.65% of shares outstanding on 13 Jan 2023 to 4.88% on 29 Dec 2023, a change of -12.77 percentage points. The year's high was 17.65% on 13 Jan 2023 and its low 4.45% on 31 Jul 2023, averaging 8.12% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.14 days on 30 Nov 2023. Full history: Immunic, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 17.65% (13 Jan 2023)
- End of year
- 4.88% (29 Dec 2023)
- Change
- -12.77 pp
- High
- 17.65% (13 Jan 2023)
- Low
- 4.45% (31 Jul 2023)
- Average
- 8.12%
- Highest days to cover
- 11.14 (30 Nov 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 17.65% | 10.85 | |
| 31 Jan 2023 | 15.19% | 3.88 | |
| 15 Feb 2023 | 13.66% | 3.83 | |
| 28 Feb 2023 | 14.31% | 7.79 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 11.20% | 4.15 | |
| 31 Mar 2023 | 10.57% | 8.64 | |
| 14 Apr 2023 | 10.91% | 1.00 | |
| 28 Apr 2023 | 9.30% | 6.54 | |
| 15 May 2023 | 7.33% | 5.31 | 10-Q filed, results (8-K) |
| 31 May 2023 | 5.24% | 3.08 | |
| 15 Jun 2023 | 4.57% | 5.09 | |
| 30 Jun 2023 | 4.88% | 1.06 | |
| 14 Jul 2023 | 4.57% | 1.00 | |
| 31 Jul 2023 | 4.45% | 2.29 | |
| 15 Aug 2023 | 4.79% | 3.77 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 5.35% | 7.58 | |
| 15 Sep 2023 | 5.60% | 10.63 | |
| 29 Sep 2023 | 5.48% | 10.53 | |
| 13 Oct 2023 | 9.73% | 1.53 | |
| 31 Oct 2023 | 7.25% | 4.86 | |
| 15 Nov 2023 | 6.55% | 4.95 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 6.15% | 11.14 | |
| 15 Dec 2023 | 5.20% | 7.83 | |
| 29 Dec 2023 | 4.88% | 6.27 |
See also: Immunic, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.